Summary

Global Remdesivir market is expected to reach USD9913.38 million by 2026. Remdesivir, a drug originally developed by Gilead Sciences, Inc. for the treatment of Ebola, is an antiviral medication belonging to the drug class of protease inhibitors. Remdesivir is a nucleotide analog particularly of adenosine, which shuts down the viral replication process by inhibiting the activity of an important viral enzyme RNA-dependent RNA polymerase. The drug basically causes mutation in viral genome and blocks polymerase enzymes function, which brings about premature termination of viral replication.

The global remdesivir market is driven by the increasing prevalence of COVID-19 pandemic across different parts of the globe. Remdesivir has been found to be effective in treating novel coronavirus disease patients across different parts of the globe. The Chinese have also been using the drug on compassionate use basis. Additionally, the drug was also used on the very first COVID-19 patient in the US, a young man in Snohomish country in Washington. He was given the drug when his condition worsened, and signs of improvement were observed on the very next day in his condition after the drug administration. A Californian patient, who the doctors thought, will not survive, also recovered after getting remdesivir. Promising results were also observed in Japan on 14 patients. After such cases and evidences, the US Food and Drug Administration granted approval to Remdesivir in Oct 2020 and the world is hoping that it will emerge out as a successful coronavirus treatment in coming years as well.

The global remdesivir market is segmented based on dosage form, route of administration, patient age, distribution channel, application, company, and region. Based on dosage form, the market can be categorized into frozen solution, and lyophilized solution. The lyophilized segment is expected to hold significant market share on account of their longer shelf life. Additionally, they are cost effective, safe and an effective way to deliver medication.

Regionally, Asia Pacific is expected to witness significant growth during the forecast period in the overall remdesivir market owing to increasing number of COVID-19 patients and huge number of hospitalization cases along with increasing demand for remdesivir for the treatment of COVID-19.

Major players operating in the global remdesivir market include Gilead Sciences, Inc., Cipla Ltd., Hetero Labs Ltd., Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.), Dr Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Jubilant Pharmova Ltd., Eva Pharma, Ferozsons Laboratories and others.
Years considered for this report:
Base Year: 2020
Estimated Year: 2021E
Forecast Period: 2022F–2026F
Objective of the Study:
• To analyze and estimate the market size of global remdesivir market in 2020.
• To estimate and forecast the market size of global remdesivir market from 2021 to 2026 and growth rate until 2026.
• To classify and forecast global remdesivir market based on dosage form, route of administration, patient age, application, distribution channel, company, and regional distribution.
• To identify dominant region or segment in the global remdesivir market.
• To identify drivers and challenges for global remdesivir market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global remdesivir market.
• To conduct pricing analysis for global remdesivir market.
• To identify and analyze the profile of leading players operating in global remdesivir market.
• To identify key sustainable strategies adopted by market players in global remdesivir market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of global remdesivir market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Remdesivir manufacturers, suppliers, distributors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to remdesivir
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global remdesivir market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Global Remdesivir Market, By Dosage Form:
o Lyophilized Solution
o Frozen Solution
• Global Remdesivir Market, By Route of Administration:
o Intravenous
o Inhalation
• Global Remdesivir Market, By Patient Age:
o Geriatric
o Adult
o Pediatric
• Global Remdesivir Market, By Application:
o SARS-CoV-2 (COVID-19)
o MERS-CoV
o Ebola
o SARS-CoV
• Global Remdesivir Market, By Distribution Channel:
o Hospitals
o Clinics
o Drug Stores and Pharmacies
• Global Remdesivir Market, By Region:
o North America
 United States
 Mexico
 Canada
o Asia-Pacific
 India
 Japan
 China
 South Korea
 Australia
o Europe
 France
 United Kingdom
 Italy
 Germany
 Spain
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 Iran
 South Africa
 UAE
 Saudi Arabia
 Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global remdesivir market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Remdesivir Market
4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness (Aided/Unaided)
5.2. Product Awareness
5.3. Customer Satisfaction Analysis
5.4. Unmet Needs/Challenges
6. Global Remdesivir Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Dosage Form (Lyophilized Solution, Frozen Solution)
6.2.2. By Route of Administration (Intravenous, Inhalation)
6.2.3. By Patient Age (Geriatric, Adult, Pediatric)
6.2.4. By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV)
6.2.5. By Distribution Channel (Hospitals, Clinics, Drug Stores and Pharmacies)
6.2.6. By Company (2020)
6.2.7. By Region
6.3. Product Market Map
7. North America Remdesivir Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Dosage Form
7.2.2. By Route of Administration
7.2.3. By Patient Age
7.2.4. By Application
7.2.5. By Distribution Channel
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Remdesivir Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Dosage Form
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By Patient Age
7.3.1.2.4. By Application
7.3.1.2.5. By Distribution Channel
7.3.2. Mexico Remdesivir Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Dosage Form
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By Patient Age
7.3.2.2.4. By Application
7.3.2.2.5. By Distribution Channel
7.3.3. Canada Remdesivir Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Dosage Form
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By Patient Age
7.3.3.2.4. By Application
7.3.3.2.5. By Distribution Channel
8. Asia-Pacific Remdesivir Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Dosage Form
8.2.2. By Route of Administration
8.2.3. By Patient Age
8.2.4. By Application
8.2.5. By Distribution Channel
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. India Remdesivir Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Dosage Form
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By Patient Age
8.3.1.2.4. By Application
8.3.1.2.5. By Distribution Channel
8.3.2. Japan Remdesivir Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Dosage Form
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By Patient Age
8.3.2.2.4. By Application
8.3.2.2.5. By Distribution Channel
8.3.3. China Remdesivir Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Dosage Form
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By Patient Age
8.3.3.2.4. By Application
8.3.3.2.5. By Distribution Channel
8.3.4. South Korea Remdesivir Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Dosage Form
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By Patient Age
8.3.4.2.4. By Application
8.3.4.2.5. By Distribution Channel
8.3.5. Australia Remdesivir Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Dosage Form
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By Patient Age
8.3.5.2.4. By Application
8.3.5.2.5. By Distribution Channel
9. Europe Remdesivir Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Dosage Form
9.2.2. By Route of Administration
9.2.3. By Patient Age
9.2.4. By Application
9.2.5. By Distribution Channel
9.2.6. By Country
9.3. Europe: Country Analysis
9.3.1. France Remdesivir Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Dosage Form
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By Patient Age
9.3.1.2.4. By Application
9.3.1.2.5. By Distribution Channel
9.3.2. United Kingdom Remdesivir Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Dosage Form
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By Patient Age
9.3.2.2.4. By Application
9.3.2.2.5. By Distribution Channel
9.3.3. Italy Remdesivir Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Dosage Form
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By Patient Age
9.3.3.2.4. By Application
9.3.3.2.5. By Distribution Channel
9.3.4. Germany Remdesivir Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Dosage Form
9.3.4.2.2. By Route of Administration
9.3.4.2.3. By Patient Age
9.3.4.2.4. By Application
9.3.4.2.5. By Distribution Channel
9.3.5. Spain Remdesivir Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Dosage Form
9.3.5.2.2. By Route of Administration
9.3.5.2.3. By Patient Age
9.3.5.2.4. By Application
9.3.5.2.5. By Distribution Channel
10. South America Remdesivir Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Dosage Form
10.2.2. By Route of Administration
10.2.3. By Patient Age
10.2.4. By Application
10.2.5. By Distribution Channel
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Remdesivir Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Dosage Form
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By Patient Age
10.3.1.2.4. By Application
10.3.1.2.5. By Distribution Channel
10.3.2. Argentina Remdesivir Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Dosage Form
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By Patient Age
10.3.2.2.4. By Application
10.3.2.2.5. By Distribution Channel
10.3.3. Colombia Remdesivir Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Dosage Form
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By Patient Age
10.3.3.2.4. By Application
10.3.3.2.5. By Distribution Channel
11. Middle East and Africa Remdesivir Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Dosage Form
11.2.2. By Route of Administration
11.2.3. By Patient Age
11.2.4. By Application
11.2.5. By Distribution Channel
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. Iran Remdesivir Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Dosage Form
11.3.1.2.2. By Route of Administration
11.3.1.2.3. By Patient Age
11.3.1.2.4. By Application
11.3.1.2.5. By Distribution Channel
11.3.2. South Africa Remdesivir Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Dosage Form
11.3.2.2.2. By Route of Administration
11.3.2.2.3. By Patient Age
11.3.2.2.4. By Application
11.3.2.2.5. By Distribution Channel
11.3.3. UAE Remdesivir Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Dosage Form
11.3.3.2.2. By Route of Administration
11.3.3.2.3. By Patient Age
11.3.3.2.4. By Application
11.3.3.2.5. By Distribution Channel
11.3.4. Saudi Arabia Remdesivir Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Dosage Form
11.3.4.2.2. By Route of Administration
11.3.4.2.3. By Patient Age
11.3.4.2.4. By Application
11.3.4.2.5. By Distribution Channel
11.3.5. Kuwait Remdesivir Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Dosage Form
11.3.5.2.2. By Route of Administration
11.3.5.2.3. By Patient Age
11.3.5.2.4. By Application
11.3.5.2.5. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Pricing Analysis
15. Patent Analysis
16. Competitive Landscape
16.1. Gilead Sciences, Inc.
16.2. Cipla Ltd.
16.3. Hetero Labs Ltd.
16.4. Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.)
16.5. Dr Reddy's Laboratories Ltd.
16.6. Sun Pharmaceutical Industries Ltd.
16.7. Cadila Healthcare Ltd.
16.8. Jubilant Pharmova Ltd.
16.9. Eva Pharma Ltd.
16.10. Ferozsons Laboratories
17. Strategic Recommendations
18. About Us & Disclaimer